ProCE Banner Activity

ExpressPoints
Asparaginase-Based Therapy in AYAs and Adults With ALL: Leveraging the Pediatric Experience

Slideset Download
Download this short summary slideset of key takeaways from a live CCO Webinar on the optimal use of pediatric asparaginase-based regimens in the treatment of a AYA and adult patients with ALL.

Released: December 20, 2021

Expiration: December 19, 2022

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Jazz Pharmaceuticals

Servier Oncology Global Medical and Patient Affairs

Servier Pharmaceuticals

Program Director Disclosure

Program Director

Wendy Stock, MD

Professor of Medicine
Section of Hematology/Oncology
Department of Medicine
The University of Chicago
Chicago, Illinois

Faculty Disclosure

Primary Author

Emily Curran, MD

Assistant Professor
Division of Hematology/Oncology
Medical Director, UCC Clinical Trials Office
University of Cincinnati Cancer Center
Cincinnati, Ohio

Dan Douer, MD

Associate Professor of Medicine-Hematology
University of Southern California/Norris
Comprehensive Cancer Center and Hospital
Los Angeles, California

Scott Howard, MD, MSc

Professor
Department of Acute and Tertiary Care
The University of Tennessee Health Science Center
Memphis, Tennessee

Stephen P. Hunger, MD

Jeffrey E. Perelman Distinguished Chair in Pediatrics
Chief, Division of Pediatric Oncology
Director, Center for Childhood Cancer Research
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania